Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Vepdegestrant is the first and only PROteolysis TArgeting Chimera (PROTAC) evaluated in a Phase 3 clinical trial and the first to show benefit in patients with breast cancer
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Annual EBITDA margin expands by 170 basis points
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Subscribe To Our Newsletter & Stay Updated